Manufacturer record
Ultratech Pharmaceuticals: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Ultratech Pharmaceuticals (Himachal Pradesh) were declared Not of Standard Quality between January 2019 and March 2019. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: UNI-390, Hydrocortisone Sodium Succinate Injection I.P. (exp Mar 2020). RDTL Guwahati (state lab) found it not of standard quality: Particulate Contamination & Assay. Listed in the March 2019 alert.
Records by type
2 records linked to Ultratech Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Hydrocortisone Sodium Succinate Injection I.P. | Batch UNI-390Mfg Apr 2018 · Exp Mar 2020 | Particulate Contamination & AssayAssay | RDTL GuwahatiState lab | Mar 2019 |
| Hydrocortisone Sodium Succinate Injection I.P. (HCORT) | Batch UNI-231Mfg Nov 2017 · Exp Oct 2019 | Sterility & Particulate ContaminationSterility | RDTL GuwahatiState lab | Jan 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.